TRADING UPDATES: Novacyt gets UK approval; Nostra spuds Cypress well
(Alliance News) - The following is a round-up of updates by London-listed companies, issued Thursday and not separately reported by Alliance News:
Read moreMon, 14th Dec 2020 14:54
(Alliance News) - The following is a round-up of updates by London-listed companies, issued Thursday and not separately reported by Alliance News:
Read more(Sharecast News) - Immunodiagnostics group Oncimmune Holdings said on Thursday that its EarlyCDT Lung test had been granted approval by the Ministry of Health for Aragon in Spain and will now be adopted in the University Hospital Miguel Servet in Zaragoza.
Read more(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:
Read more(Sharecast News) - Oncimmune announced the publication of a paper arising from the research collaboration with Cedars-Sinai Medical Center in Los Angeles on Friday, focusing on the sex-specific autoimmune reactivity to SARS-CoV-2 - the virus which causes Covid-19 - following mildly symptomatic infection.
Read moreOncimmune study suggests antibodies spike following Covid infection
Read moreOncimmune shares up after multiple commercial contract wins
Read more(Sharecast News) - Oncimmune Holdings announced on Tuesday that it has signed further commercial contracts within its 'ImmunoINSIGHTS' pharma services business.
Read moreUK shareholder meetings calendar - next 7 days
Read moreTRADING UPDATES: Annual profit rises for UP Global Sourcing, Beximco
Read moreAIM WINNERS & LOSERS: Warpaint sees profit topping market forecasts
Read moreEXECUTIVE CHANGES: TP chair resigns amid pressure from Science Group
Read moreUK earnings, trading statements calendar - next 7 days
Read moreOncimmune inks profiling contract with unnamed global pharma company
Read more(Sharecast News) - Immunodiagnostics company Oncimmune has signed an autoantibody profiling agreement with an unnamed global pharmaceutical company, it announced on Monday, to evaluate the autoantibody profiles of patient samples in various autoimmune diseases.
Read more(Sharecast News) - Immunodiagnostics group Oncimmune announced the pre-publication of the three-year follow-up data for the 'Early detection of Cancer of the Lung Scotland' (ECLS) trial on Monday, which showed that after three years, the number of late-stage cancers and deaths were lower in patients tested with the 'EarlyCDT Lung' blood test.
Read more